Sbi Securities Co., Ltd. Actinium Pharmaceuticals, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 542 shares of ATNM stock, worth $655. This represents 0.0% of its overall portfolio holdings.
Number of Shares
542Holding current value
$655% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ATNM
# of Institutions
76Shares Held
8.42MCall Options Held
65.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY1.88MShares$2.27 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$1.97 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA686KShares$830,2450.0% of portfolio
-
State Street Corp Boston, MA603KShares$729,2050.0% of portfolio
-
Acadian Asset Management LLC Boston, MA454KShares$548,9690.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $30.5M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...